CURE - Oncology & Cancer News for Patients & Caregivers
WEBThe Solitude of Reality With Multiple Myeloma. My Tumors: A Poem Inspired By Stevenson’s ‘My Shadow’. I Am in Here: A Poem About Life With Cancer. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Long-Term Follow-Up Shows Keytruda Continues to Improve
WEBFeb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE …
Pluvicto Improves Survival Without Progression in Certain
WEBOct 23, 2023 · Pluvicto improved progression-free survival in certain patients with prostate cancer, recent research showed. Treatment with Pluvicto (177-Lu-PSMA-617) improved the duration of time when a patient’s disease did not progress with a favorable safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC) who were taxane ...
CURE
WEBImmunotherapy Special Issue 2021. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
CURE Remembers MJH Life Sciences Founder Michael J. Hennessy
WEBDec 6, 2021 · Michael J. Hennessy, 61, the son of John J. Hennessy and Vincent Ann (Lamenza) Hennessy, was born in New Brunswick, NJ and resided in Marco Island, Florida, died on Sunday, November 21, 2021, in Marco Island, Florida. Mike was preceded in death by his college sweetheart and beloved wife of 36 years, Patrice Lynn Hennessy of …
Years Later, the Decision to Walk Away from Aromatase Inhibitors …
WEBApr 24, 2021 · The decision to walk away from taking aromatase inhibitors is a choice many women are now making. Women are doing research and realizing they have a right to make the best choice for their health. Aromatase inhibitors (AIs), are a standard part of many cancer fighting plans. They are used to help fight cancer cell regrowth by blocking cell ...
Esophagitis: A Common Radiation Side Effect - Curetoday
WEBMar 24, 2005 · Radiation-induced esophagitis, the inflammation of the esophagus, is an unpleasant but temporary side effect of radiation therapy. Esophagitis is common in people who receive radiation therapy to the chest area for cancer of the esophagus as well as other cancers, including lung cancer and lymphoma. Esophagitis feels like an internal sunburn ...
FDA Approves Biosimilar Ruxience: Here's What You Need to …
WEBJul 24, 2019 · With the Food and Drug Administration’s (FDA) approval of Ruxience (rituximab-pvvr), a biosimilar to Rituxan (rituximab), patients with certain types of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) may have improved access to a more affordable treatment option, according to Lee Greenberger, an expert …
Donating My Body After Cancer: My Final Gift to the Science
WEBAug 28, 2019 · This made opting for cremation an easy choice. Another easy choice for me was choosing to donate my body to science, or more specifically to my local university medical school. Like a last parting gift of gratitude to science for keeping me alive far longer than it should have, I want to return my body to science as a teaching tool for the next ...
What Patients With Cancer Need to Know About Selecting a
WEBMar 25, 2021 · Therefore, it is key for patients with cancer, and their caregivers, to understand their options when it comes to health insurance, and components they should keep in mind when picking a plan. CURE spoke with Monica Fawzy Bryant, chief operating officer of Triage Cancer, about health insurance options and what patients with cancer …
Skip to content